Skip to main content
. 2015 Sep 14;309(9):H1528–H1542. doi: 10.1152/ajpheart.00070.2015

Fig. 3.

Fig. 3.

Effects of NPY1–36 (A and B) and PYY1–36 (C and D) in the absence or presence of sitagliptin (1 μmol/l) on cell number in SHR (A and C) and WKY (B and D) CFs pretreated with BIBP3226 (1 μmol/l). Cells were treated for 4 days with the indicated treatments. Sample sizes (n individual experiments) are shown.